BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2774058)

  • 21. Primary cutaneous lymphomas other than mycosis fungoides.
    Gilliam AC; Wood GS
    Semin Oncol; 1999 Jun; 26(3):290-306. PubMed ID: 10375086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
    Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
    Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 oncoprotein expression in cutaneous lymphoproliferations.
    Beylot-Barry M; Vergier B; DeMascarel A; Beylot C; Merlio JP
    Arch Dermatol; 1995 Sep; 131(9):1019-24. PubMed ID: 7661603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives].
    Rijlaarsdam JU; Willemze R
    Ann Dermatol Venereol; 1993; 120(1):100-6. PubMed ID: 8338321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotyping of cutaneous lymphoid infiltrates in frozen and paraffin-embedded tissue sections: a comparative study.
    Cerroni L; Smolle J; Soyer HP; Martinez Aparicio A; Kerl H
    J Am Acad Dermatol; 1990 Mar; 22(3):405-13. PubMed ID: 2179300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.
    Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W
    J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis of cutaneous large cell lymphomas using monoclonal antibodies reactive in paraffin-embedded skin biopsy specimens.
    Beljaards RC; Meijer CJ; Scheffer E; van der Valk P; Willemze R
    Am J Dermatopathol; 1991 Aug; 13(4):342-9. PubMed ID: 1928619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous Ki-1 lymphoma: pathology, immunology and clinical characteristics.
    Kadin ME
    Princess Takamatsu Symp; 1987; 18():187-95. PubMed ID: 3506541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of proliferation-associated antigens in cutaneous lymphoid infiltrates].
    Baba N
    Nihon Hifuka Gakkai Zasshi; 1990 Apr; 100(5):567-73. PubMed ID: 2395218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates.
    Ralfkiaer E; Bosq J; Gatter KC; Schwarting R; Gerdes J; Stein H; Mason DY
    Arch Dermatol Res; 1987; 279(5):285-92. PubMed ID: 2820316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of monoclonal antibodies (UCHL1, Ki-B3) against T and B cell antigens in routine paraffin-embedded skin biopsy specimens.
    Sterry W; Hauschild A
    J Am Acad Dermatol; 1989 Jul; 21(1):98-107. PubMed ID: 2473100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New monoclonal antibodies against B-cell antigens: possible new strategies for diagnosis of primary cutaneous B-cell lymphomas.
    Fanoni D; Tavecchio S; Recalcati S; Balice Y; Venegoni L; Fiorani R; Crosti C; Berti E
    Immunol Lett; 2011 Jan; 134(2):157-60. PubMed ID: 20951741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraffin section immunohistochemistry. I. Non-Hodgkin's lymphoma.
    Hall PA; d'Ardenne AJ; Stansfeld AG
    Histopathology; 1988 Aug; 13(2):149-60. PubMed ID: 3262564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.